| Subclinical hypothyroidism and autoimmune thyroiditis in pregnancy--a study in south Indian subjects. R Gayathri, S Lavanya, K Raghavan The Journal of the Association of Physicians of India 57, 691-693, 2009 | 89 | 2009 |
| Bispecific T‐cell engagers for treatment of multiple myeloma G Ravi, LJ Costa American Journal of Hematology 98, S13-S21, 2023 | 27 | 2023 |
| Current approach to Waldenström macroglobulinemia G Ravi, P Kapoor Cancer Treatment and Research Communications 31, 100527, 2022 | 13 | 2022 |
| Predictors and outcomes of acyclovir-resistant herpes simplex virus infection among hematopoietic cell transplant recipients: case-case-control investigation. D Patel, D Marchaim, G Marcus, R Gayathri, PR Lephart, T Lazarovitch, ... | 13 | 2014 |
| Current diagnosis, risk stratification and treatment paradigms in newly diagnosed multiple myeloma G Ravi, WI Gonsalves Cancer treatment and research communications 29, 100444, 2021 | 9 | 2021 |
| Real-world applicability of commercial chimeric antigen receptor T-cell therapy among older adults with relapsed and/or refractory multiple myeloma S Giri, S Bal, KN Godby, G Ravi, D Clark, C Ubersax, A Cooley, P White, ... American journal of hematology 97 (4), E153-E155, 2022 | 8 | 2022 |
| Physical activity and sleep measures using a fitness tracking device during hematopoietic cell transplantation: a pilot study N El Jurdi, N Nock, P Fu, S Cao, JM Cotton, N Ali, G Ravi, R Pinto, ... Transplantation and Cellular Therapy 27 (6), 502. e1-502. e6, 2021 | 6 | 2021 |
| Drug class refractoriness, not number of prior lines of therapy, properly classify patients with relapsed and refractory multiple myeloma. LJ Costa, S Giri, S Bal, G Ravi, KN Godby British Journal of Haematology 200 (6), 2023 | 5 | 2023 |
| Does recipient body mass index inform donor selection for allogeneic haematopoietic cell transplantation? MY Abou‐Ismail, R Fraser, M Allbee‐Johnson, L Metheny III, G Ravi, ... British journal of haematology 197 (3), 326-338, 2022 | 4 | 2022 |
| High dose fractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone (mHyperCVAD) is an active regimen in heavily pretreated relapsed/refractory multiple … N Watts, S Giri, KN Godby, G Ravi, LJ Costa, S Bal Blood 138, 3784, 2021 | 4 | 2021 |
| Protamine sulfate for the reversal of enoxaparin associated hemorrhage beyond 12 h BR Lauer, RA Nelson, JH Adamski, J Gibbons, MR Janko, G Ravi, ... The American Journal of Emergency Medicine 37 (1), 174. e5-174. e6, 2019 | 4 | 2019 |
| Increased risk of venous thromboembolism in primary central nervous system lymphoma patients undergoing therapy G Ravi, B Cooper, EL Campagnaro, BM William, RJ Creger, SL Gerson, ... Blood 124 (21), 5431, 2014 | 4 | 2014 |
| Health Outcome Preferences Among Older Adults with Multiple Myeloma Undergoing Systemic Therapy M Arias, C Ubersax, A Tucker, S Bal, G Ravi, K Godby, L Costa, ... Blood 142, 2400, 2023 | 2 | 2023 |
| Outcomes of Patients with Newly Diagnosed Multiple Myeloma Experiencing Treatment Failure after Upfront Quadruplet Therapy and Autologous Stem Cell Transplantationgayathri Ravi … G Ravi, S Bal, K Godby, S Giri, C Ubersax, A Tucker, L Costa Blood 142, 1989, 2023 | 2 | 2023 |
| Drug Class Refractoriness, Not Number of Prior Lines of Therapy (LOT), Properly Classify Patients with Relapsed and Refractory Multiple Myeloma (RRMM) Receiving Contemporary … LJ Costa, KN Godby, G Ravi, S Giri, S Bal Blood 140 (Supplement 1), 10084-10085, 2022 | 2 | 2022 |
| Disparities in clinical trial participation among older adults with multiple myeloma in the United States P White, A Cooley, S Bal, K Godby, G Ravi, D Clark, C Ubersax, ... Journal of geriatric oncology 13 (8), 1241-1243, 2022 | 2 | 2022 |
| Beyond BCMA: Outcomes of relapsed/refractory multiple myeloma after progression on anti-BCMA T cell redirecting therapy. S Arora, S Giri, KN Godby, G Ravi, LJ Costa, S Bal Journal of Clinical Oncology 40 (16_suppl), e20026-e20026, 2022 | 2 | 2022 |
| Stem cell transplant minimizes insurance coverage-driven outcome disparities for multiple myeloma patients H Schmikla, G Ravi, M de Lima, JJ Driscoll, L Bayat, E Malek Biology of Blood and Marrow Transplantation 26 (3), S46, 2020 | 2 | 2020 |
| Understanding health outcome preferences of older adults diagnosed with multiple myeloma S Maheshwari, M Arias, C Ubersax, A Tucker, S Bal, G Ravi, K Godby, ... Journal of Geriatric Oncology 15 (5), 101781, 2024 | 1 | 2024 |
| Subsequent therapy and outcomes in patients with newly diagnosed multiple myeloma experiencing disease progression after quadruplet combinations G Ravi, S Bal, L Joiner, S Giri, M Sentell, T Hill, KN Godby, LJ Costa British Journal of Haematology 204 (4), 1300-1306, 2024 | 1 | 2024 |
